News

Key Takeaways from the Global Myeloma Action Network (GMAN) SummitMyeloma Canada recently attended the annual Global Myeloma Action Network (GMAN) Summit in Sweden, where the global myeloma community came together to share ideas and advance access to care worldwide.Chief Mission Officer Michelle Oana shares her key takeaways, including promising data on quad therapies, encouraging results for peop

Myeloma Canada’s 2025 Aldo Del Col Research Grant: Four Projects What does the future of myeloma research look like? Find out how Canadian researchers are shaping it. Supported by the 2025 Aldo Del Col Research Grant, named in honour of Myeloma Canada's co-founder, four Canadian researchers are working toward a future where life is uninterrupted by myeloma. Learn more:https://myeloma.ca/2026/04/16

Dear community,The following is a press release issued by Myeloma Canada in the wake of learning that the pan-Canadian Pharmaceutical Alliance (pCPA) has terminated reimbursement negotiations – without agreement – for Carvykti®, an extremely promising new CAR T-cell therapy for myeloma patients. This issue will be an ongoing campaign and is not likely to be resolved in the short term as reimbursem